Impact of safety warnings for fluoroquinolones on prescribing behaviour. Results of a cohort study with outpatient routine data.

Ulrike Georgi Falko Tesch Jochen SchmittKatja de With

Published in: Infection (2020)

This study observed an impact on prescribing behaviour in response to regulatory safety warnings for two out of three warnings. Information on therapeutic alternatives should be a part of any safety warning to encourage the intended changes in prescribing behaviour.

Keyphrases

primary care
adverse drug
transcription factor
electronic health record
healthcare
emergency department
clinical practice
machine learning
health information
artificial intelligence
data analysis